Researchphilia Daily: Gene Therapy Wins, Semaglutide and Frailty, and a New Albumin

Today we cover a long-term gene therapy success for Wiskott-Aldrich syndrome, a frailty-stratified look at semaglutide's heart benefits from the SELECT trial, a new enzyme link between RNA methylation and cardiac aging, gamma-delta T cells as an immunotherapy target in small cell lung cancer, a head-to-head trial of lab-made versus plasma albumin for cirrhotic ascites, and a new metabolic score for predicting multiple chronic diseases. Plus a quick rundown of four more studies worth knowing about.